Matches in SemOpenAlex for { <https://semopenalex.org/work/W2891930750> ?p ?o ?g. }
- W2891930750 endingPage "3482" @default.
- W2891930750 startingPage "3473" @default.
- W2891930750 abstract "Splenectomy during cytoreductive surgery in epithelial ovarian cancer Hengzi Sun,1 Xiaoning Bi,1 Dongyan Cao,1 Jiaxin Yang,1 Ming Wu,1 Lingya Pan,1 Huifang Huang,1 Ge Chen,2 Keng Shen1 1Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; 2Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China Background: The aim of the study was to analyze the underlying causes and application of splenectomy in patients with epithelial ovarian cancer (EOC) and assess its effect on the surgical satisfaction and prognosis of these patients.Materials and methods: Clinical data of patients with ovarian epithelial cancer treated with cytoreductive surgery were collected from 2000 to 2015 at Peking Union Medical College Hospital.Results: A total of 2,882 patients underwent ovarian cancer cytoreductive surgery at Peking Union Medical College Hospital between 2000 and 2015, of whom 38 (1.3%) also underwent spleen resections. Of these 38 patients, one underwent splenectomy due to intraoperative trauma, whereas the remaining 37 patients underwent splenectomy due to splenic metastasis. Among these 37 patients, 27 underwent resection due to direct tumor spread in the spleen and 10 underwent resection due to hematogenous metastasis. For subsequent first-line chemotherapy, 22 patients were platinum sensitive and 15 were platinum resistant. Overall median survival and the postsplenectomy median survival time were 106 and 75 months, respectively. The overall median survival in secondary cytoreduction was 101 months compared with 20.3–56 months in literature reviews. Univariate analysis revealed that platinum resistance to first-line chemotherapy, suboptimal surgery, and hematogenous metastasis influenced survival. Chemosensitivity and residual disease were identified as independent risk factors by multivariate analysis. We also report a literature review concerning the efficacy and safety of splenectomy during cytoreductive surgery in EOC.Conclusion: Approximately 1.3% of patients with EOC underwent spleen resection during initial cytoreductive surgery and more often during recytoreductive surgery. Tumor involvement was the most common indication for splenectomy, and rare patients underwent splenectomy due to intraoperative trauma. Most patients achieved optimal surgery, and thus their overall survival and postsplenectomy survival rates were longer. The prognosis of patients was closely related to chemosensitivity and presence of residual tumors. Splenectomy should be attempted in all patients with splenic involvement in whom optimal cytoreductive surgery was achievable, no matter in primary or secondary cytoreduction. Keywords: optimal debulking surgery, chemosensitivity, postoperative complication, splenic involvement, metastasis, prognosis" @default.
- W2891930750 created "2018-09-27" @default.
- W2891930750 creator A5015346654 @default.
- W2891930750 creator A5016968509 @default.
- W2891930750 creator A5026373546 @default.
- W2891930750 creator A5026498644 @default.
- W2891930750 creator A5036163975 @default.
- W2891930750 creator A5046238628 @default.
- W2891930750 creator A5059185619 @default.
- W2891930750 creator A5060469228 @default.
- W2891930750 creator A5068588368 @default.
- W2891930750 date "2018-09-01" @default.
- W2891930750 modified "2023-09-26" @default.
- W2891930750 title "Splenectomy during cytoreductive surgery in epithelial ovarian cancer" @default.
- W2891930750 cites W1486932945 @default.
- W2891930750 cites W1606591815 @default.
- W2891930750 cites W1835777170 @default.
- W2891930750 cites W1922469696 @default.
- W2891930750 cites W1964525720 @default.
- W2891930750 cites W1965155043 @default.
- W2891930750 cites W1970650020 @default.
- W2891930750 cites W1970875645 @default.
- W2891930750 cites W197184898 @default.
- W2891930750 cites W1986106931 @default.
- W2891930750 cites W2002166126 @default.
- W2891930750 cites W2009310985 @default.
- W2891930750 cites W2013388187 @default.
- W2891930750 cites W2021186541 @default.
- W2891930750 cites W2023744555 @default.
- W2891930750 cites W2028466095 @default.
- W2891930750 cites W2030063856 @default.
- W2891930750 cites W2031432768 @default.
- W2891930750 cites W2044644720 @default.
- W2891930750 cites W2066098954 @default.
- W2891930750 cites W2088749564 @default.
- W2891930750 cites W2092388421 @default.
- W2891930750 cites W2095558655 @default.
- W2891930750 cites W2122763619 @default.
- W2891930750 cites W2129084512 @default.
- W2891930750 cites W2137005937 @default.
- W2891930750 cites W2154175915 @default.
- W2891930750 cites W2155884268 @default.
- W2891930750 cites W2163602886 @default.
- W2891930750 cites W2164621050 @default.
- W2891930750 cites W2170192029 @default.
- W2891930750 cites W2171183942 @default.
- W2891930750 cites W2266578854 @default.
- W2891930750 cites W2272984102 @default.
- W2891930750 cites W2288907497 @default.
- W2891930750 cites W2316501478 @default.
- W2891930750 cites W2327614675 @default.
- W2891930750 cites W2350476508 @default.
- W2891930750 cites W2397527628 @default.
- W2891930750 cites W2411472826 @default.
- W2891930750 cites W2495646858 @default.
- W2891930750 cites W2569695585 @default.
- W2891930750 cites W2624217409 @default.
- W2891930750 cites W2794788563 @default.
- W2891930750 cites W2799652446 @default.
- W2891930750 doi "https://doi.org/10.2147/cmar.s172687" @default.
- W2891930750 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6140729" @default.
- W2891930750 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30254490" @default.
- W2891930750 hasPublicationYear "2018" @default.
- W2891930750 type Work @default.
- W2891930750 sameAs 2891930750 @default.
- W2891930750 citedByCount "13" @default.
- W2891930750 countsByYear W28919307502020 @default.
- W2891930750 countsByYear W28919307502021 @default.
- W2891930750 countsByYear W28919307502022 @default.
- W2891930750 countsByYear W28919307502023 @default.
- W2891930750 crossrefType "journal-article" @default.
- W2891930750 hasAuthorship W2891930750A5015346654 @default.
- W2891930750 hasAuthorship W2891930750A5016968509 @default.
- W2891930750 hasAuthorship W2891930750A5026373546 @default.
- W2891930750 hasAuthorship W2891930750A5026498644 @default.
- W2891930750 hasAuthorship W2891930750A5036163975 @default.
- W2891930750 hasAuthorship W2891930750A5046238628 @default.
- W2891930750 hasAuthorship W2891930750A5059185619 @default.
- W2891930750 hasAuthorship W2891930750A5060469228 @default.
- W2891930750 hasAuthorship W2891930750A5068588368 @default.
- W2891930750 hasBestOaLocation W28919307501 @default.
- W2891930750 hasConcept C121608353 @default.
- W2891930750 hasConcept C126322002 @default.
- W2891930750 hasConcept C141071460 @default.
- W2891930750 hasConcept C2776309230 @default.
- W2891930750 hasConcept C2779013556 @default.
- W2891930750 hasConcept C2780427987 @default.
- W2891930750 hasConcept C2780931953 @default.
- W2891930750 hasConcept C61434518 @default.
- W2891930750 hasConcept C71924100 @default.
- W2891930750 hasConceptScore W2891930750C121608353 @default.
- W2891930750 hasConceptScore W2891930750C126322002 @default.
- W2891930750 hasConceptScore W2891930750C141071460 @default.
- W2891930750 hasConceptScore W2891930750C2776309230 @default.
- W2891930750 hasConceptScore W2891930750C2779013556 @default.
- W2891930750 hasConceptScore W2891930750C2780427987 @default.
- W2891930750 hasConceptScore W2891930750C2780931953 @default.
- W2891930750 hasConceptScore W2891930750C61434518 @default.